Charles Schwab’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Charles Schwab’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-25,300	Closed	-$321K	–	3135
2014 Q3	$321K	Hold	25,300	–	–	﹤0.01%	2770
2014 Q2	$431K	Hold	25,300	–	–	﹤0.01%	2690
2014 Q1	$358K	Hold	25,300	–	–	﹤0.01%	2729
2013 Q4	$324K	Buy	25,300 +12,300	+95%	+$129K	﹤0.01%	2771
2013 Q3	$117K	Hold	13,000	–	–	﹤0.01%	3021
2013 Q2	$100K	Buy	+13,000	New	+$95.4K	﹤0.01%	3025

Charles Schwab's DRTX Position: Q4 2014 in Review

Charles Schwab sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 25,300 shares — an estimated $321K sold.

Charles Schwab first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $431K in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

Charles Schwab reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Charles Schwab sold 25,300 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $321K.
Charles Schwab first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
Charles Schwab's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $431K in Q2 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Charles Schwab's 13F filing for Q4 2014, filed 17 Feb 2015.